Media cover potential impacts to OHSU, Oregon and scientific research in the U.S. if the NIH reduction of indirect costs holds. “There’s 1,900 research workers at OHSU and I don’t think any of them feel safe. I know I don’t feel safe,” says Lynne Swarbrick, B.S.

Researchers at Oregon Health & Science University have developed a test called PAC-MANN, the abbreviation for “protease activity-based assay using a magnetic nanosensor,” which uses a small blood sample to detect changes in protease activity — a key indicator of pancreatic ductal adenocarcinoma, or PDAC, the most common and deadly form of pancreatic cancer.

The Oregon Poison Center reminds the public about the risk of carbon monoxide poisoning during a dip in temperatures and persistent winter weather across the state. “This is the perfect time to check your battery-operated carbon monoxide detector or install one on every level of your home if you haven’t already done so,” says Rob Hendrickson, M.D. “If you need to use a generator or alternative cooking source, it is extremely important to place them outside, well away from windows, doors and ventilation systems.”

A team of OHSU researchers led by Jared Fischer, Ph.D., and Jose Montoya Mira, Ph.D., have developed a new blood test that identifies hard-to-detect pancreatic cancer with 85% accuracy. Fischer says, “The problem with pancreatic cancer is that we often catch it too late. Our goal with PAC-MANN is to give clinicians a tool that can detect the disease much earlier, when more treatment options are available and there is a better chance of survival.”

A team of OHSU researchers led by Jared Fischer, Ph.D., and Jose Montoya Mira, Ph.D., have developed a new blood test that identifies hard-to-detect pancreatic cancer with 85% accuracy. Fischer says, “The problem with pancreatic cancer is that we often catch it too late. Our goal with PAC-MANN is to give clinicians a tool that can detect the disease much earlier, when more treatment options are available and there is a better chance of survival.”

A team of OHSU researchers led by Jared Fischer, Ph.D., and Jose Montoya Mira, Ph.D., have developed a new blood test that identifies hard-to-detect pancreatic cancer with 85% accuracy. Fischer says, “The problem with pancreatic cancer is that we often catch it too late. Our goal with PAC-MANN is to give clinicians a tool that can detect the disease much earlier, when more treatment options are available and there is a better chance of survival.”

Media cover potential impacts to OHSU, Oregon and scientific research in the U.S. if the NIH reduction of indirect costs holds. “There’s 1,900 research workers at OHSU and I don’t think any of them feel safe. I know I don’t feel safe,” says Lynne Swarbrick, B.S.

“There is a huge need for developing new ways of detecting pancreatic cancer early,” says study co-author Jared Fischer, a molecular biologist at Oregon Health & Science University (OHSU) in Portland.

As temperatures dip and winter weather persists throughout Oregon, the Oregon Poison Center at OHSU reminds the public about the risk of carbon monoxide poisoning; Rob Hendrickson, M.D., says: “This is the perfect time to check your battery-operated carbon monoxide detector or install one on every level of your home if you haven’t already done so. If you need to use a generator or alternative cooking source, it is extremely important to place them outside, well away from windows, doors and ventilation systems.”

In a Malheur Enterprise story about the need for volunteers to open a warming shelter during extremely cold overnight weather in Ontario, Sean Robinson, M.D., says, “If you guys are in the single digits, rallying the troops or getting local government to do something is of upmost importance, or you’re going to have some deaths on your hands.”